Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -106,060 | -174,990 | N/A |
| Depreciation Amortization | 77,652 | 116,575 | N/A |
| Accounts payable and accrued liabilities | 553 | 121 | N/A |
| Other Working Capital | 506 | 625 | N/A |
| Other Operating Activity | 20,778 | 56,724 | 0 |
| Operating Cash Flow | $-6,571 | $-945 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -6 | -1 | N/A |
| Purchase Sale Intangibles | -161 | N/A | N/A |
| Other Investing Activity | -161 | 0 | 0 |
| Investing Cash Flow | $-166 | $-1 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 599 | 146 | N/A |
| Debt Repayment | -100 | N/A | N/A |
| Common Stock Issued | 6,553 | 1,137 | N/A |
| Other Financing Activity | -222 | -60 | 0 |
| Financing Cash Flow | $6,831 | $1,223 | $N/A |
| Beginning Cash Position | 313 | 0 | N/A |
| End Cash Position | 407 | 313 | N/A |
| Net Cash Flow | $94 | $313 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -6,571 | -945 | N/A |
| Capital Expenditure | -6 | -1 | N/A |
| Free Cash Flow | -6,577 | -946 | 0 |